QuidelOrtho CorpQDEL決算レポート
Nasdaq · health care industry
クイデルオーソ社は米国の診断用医療品メーカーで、世界中で製品を販売しています。体外診断分野で深い実績を持ち、医療機関などに専門的な検査ソリューションを提供し、世界の医療サービスの効率化を支援しています。
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 14.00% | 9.4M | ▲ +1.00pp | 2024-11-14 |
| BlackRock, Inc. | 10.80% | 7.3M | ▲ +3.60pp | 2024-10-07 |
| The Vanguard Group | 10.13% | 6.8M | ▲ +1.13pp | 2024-12-06 |
| Rubric | 6.25% | 4.2M | — | 2024-11-13 |
| The | 0.00% | 219.8M | ▼ -13.00pp | 2024-11-21 |
インサイダー取引
Net 90d: +$647.7K · buys $647.7K / sells $0期間:
種別:
役職:
| インサイダー | 役職 | 種別 | ||||
|---|---|---|---|---|---|---|
| 2026-03-28 | Busky Joseph M. | Chief Financial Officer | Grant | 4.9K | $0.00 | $0 |
| 2026-02-13 | Busky Joseph M. | Chief Financial Officer | Buy (open market) | 3.4K | $23.66 | $79.7K |
| 2026-02-13 | Matthew Strobeck | Director | Buy (open market) | 10.0K | $23.96 | $239.6K |
| 2026-02-13 | Blaser Brian J. | President and CEO | Buy (open market) | 10.5K | $23.59 | $248.7K |
| 2026-02-13 | Busky Joseph M. | Chief Financial Officer | Buy (open market) | 3.4K | $23.66 | $79.7K |
| 2026-02-08 | Hodges Michelle A | Chief Legal Officer | Grant | 3.2K | $0.00 | $0 |
| 2026-02-08 | Busky Joseph M. | Chief Financial Officer | Grant | 6.0K | $0.00 | $0 |
| 2026-01-31 | Hodges Michelle A | Chief Legal Officer | Grant | 1.6K | $0.00 | $0 |
| 2026-01-31 | Hodges Michelle A | Chief Legal Officer | Grant | 1.8K | $0.00 | $0 |
| 2026-01-31 | McLellan Philip D. | Chief Operations Officer | Grant | 1.1K | $0.00 | $0 |
1–10 of 19
1 / 2 ページ